Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:I-282-I-287
doi: 10.1161/hc37t1.094856
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagashima, H.
Right arrow Articles by Kasanuki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagashima, H.
Right arrow Articles by Kasanuki, H.
Related Collections
Right arrow Apoptosis

(Circulation. 2001;104:I-282.)
© 2001 American Heart Association, Inc.


Aortic and Peripheral Vascular Surgery

Angiotensin II Type 2 Receptor Mediates Vascular Smooth Muscle Cell Apoptosis in Cystic Medial Degeneration Associated With Marfan’s Syndrome

Hirotaka Nagashima, MD, PhD; Yasunari Sakomura, MD, PhD; Yoshikazu Aoka, MD; Kenta Uto, MD; Kin-ichi Kameyama, MD; Motoko Ogawa, MD; Shigeyuki Aomi, MD, PhD; Hitoshi Koyanagi, MD, PhD; Naoko Ishizuka, MD, PhD; Mitsuhide Naruse, MD, PhD; Masatoshi Kawana, MD, PhD; Hiroshi Kasanuki, MD, PhD

From the Departments of Cardiology (H.N., Y.S., Y.A., K.U., K.K., M.O., N.I., M.K., H. Kasanuki) and Cardiovascular Surgery (S.A., H. Koyanagi), The Heart Institute of Japan, and the Second Department of Medicine (M.N.), Tokyo Women’s Medical University, Tokyo, Japan.

Reprint requests to Hirotaka Nagashima, MD, PhD, Department of Cardiology, The Heart Institute of Japan, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjyuku-ku, Tokyo162-8666, Japan. E-mail mnagasih{at}hij.twmu.ac.jp

Background— Cystic medial degeneration (CMD) is a histological abnormality that is common in the aortic diseases associated with Marfan’s syndrome (MFS). Although little known about the mechanism underlying CMD, several recent reports have demonstrated that vascular smooth muscle cell (VSMC) apoptosis could play a substantial role in CMD. On the other hand, angiotensin II (Ang II) has been reported to play an important role in the regulation of VSMC growth and apoptosis via the Ang II type 1 receptor (AT1R) and type 2 receptor (AT2R).

Methods and Results— To elucidate the role of Ang II signaling via the Ang II receptors in CMD, we investigated AT1R and AT2R mRNA expression and tissue concentration of Ang II in MFS aortas (n=10) and control aortas (n=12). Furthermore, we examined the effects of an ACE inhibitor, an AT1R blocker, and an AT2R blocker on serum deprivation-induced VSMC apoptosis by organ culture system. AT1R expression was significantly decreased (P<0.01) and AT2R expression was significantly increased (P<0.001) in MFS aortas compared with control aortas, and tissue Ang II concentration was significantly higher in CMD than in the control condition (P<0.01). Both the ACE inhibitor and AT2R blocker significantly inhibited serum deprivation-induced VSMC apoptosis (P<0.05), although the AT1R blocker did not inhibit apoptosis in cultured aortic media from MFS patients.

Conclusions— Accelerated ACE-dependent Ang II formation and signaling via upregulated AT2R play a pivotal role in VSMC apoptosis in CMD, and the ACE inhibitor could have clinical value in the prevention and treatment of CMD.


Key Words: angiotensin • receptors • apoptosis • muscle, smooth • aorta